The OVARIO trial supports niraparib plus bevacizumab as feasible maintenance therapy in advanced ovarian cancer post-platinum chemotherapy, with consistent long-term results. Median PFS was 19.6 ...
EDMONd: A feasibility study of elemental diet as an alternative to parenteral nutrition for ovarian cancer patients with inoperable malignant bowel obstruction. This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results